Search Results - "Feltgen, N"

Resolving the clinical acuity categories “hand motion” and “counting fingers” using the Freiburg Visual Acuity Test (FrACT) by Lange, C., Feltgen, N., Junker, B., Schulze-Bonsel, K., Bach, M.

“…Purpose The Freiburg Visual Acuity Test (FrACT) has been suggested as a promising test for quantifying the visual acuity (VA) of patients with very low vision,…”
Get full text

Demographics of patients receiving Intravitreal anti-VEGF treatment in real-world practice: healthcare research data versus randomized controlled trials by Ziemssen, F, Feltgen, N, Holz, F G, Guthoff, R, Ringwald, A, Bertelmann, T, Wiedon, A, Korb, C

“…While randomized controlled trials (RCTs) are based on strict inclusion/exclusion criteria, non-interventional studies (NISs) might provide additional…”
Get full text

A randomized, open-label, multicenter study of switching to brolucizumab with or without a loading dose for patients with suboptimal anatomically controlled neovascular age-related macular degeneration—the FALCON study by Holz, F. G., Schmitz-Valckenberg, Steffen, Wolf, A., Agostini, H., Lorenz, K., Pielen, A., Feltgen, N., Guthoff, R., Quiering, C., Clemens, A., Jaeger, K.

“…Background Treatment initiation with brolucizumab, a new potent anti-vascular endothelial growth factor (VEGF) agent, is typically performed with three monthly…”
Get full text

Buckling Surgery: Old Fashioned or Cutting Edge? by Feltgen, N, Hoerauf, H

“…For many decades, scleral buckling surgery was the only reasonable surgical procedure in eyes with primary rhegmatogenous retinal detachment. In recent years,…”
Get more information

Visual Acuity (VA) Outcomes and Impact of Baseline (BL) Perfusion Status in VIBRANT by Feltgen, N., Asmus, F.

“…Purpose Report additional VA outcomes from VIBRANT. Methods VIBRANT was a phase 3 study of intravitreal aflibercept (IVT‐AFL) vs laser for macular edema (ME)…”
Get full text

Correlation between central corneal thickness, applanation tonometry, and direct intracameral IOP readings by Feltgen, Nicolas, Leifert, Dorothee, Funk, Jens

“…BACKGROUND Several authors reported incorrect high intraocular pressure (IOP) values in eyes with a thick cornea using applanation tonometry. This hypothesis…”
Get full text

Rapamycin reduces VEGF expression in retinal pigment epithelium (RPE) and inhibits RPE-induced sprouting angiogenesis in vitro by Stahl, A., Paschek, L., Martin, G., Gross, N.J., Feltgen, N., Hansen, L.L., Agostini, H.T.

“…Anti-VEGF treatment has become accepted first-line treatment for choroidal neovascularisation (CNV) in age-related macular degeneration. However,…”
Get full text

Regression of idiopathic epiretinal membrane-Case report and consideration of the possible mechanism by Framme, C, Feltgen, N, Schumann, R, Stichtenoth, D O, Hattenbach, L O

“…In the presence of a symptomatic epiretinal gliosis, pars plana vitrectomy with membrane peeling to remove the membrane is usually indicated in clinical…”
Get full text

Distribution of internal carotid artery plaque locations among patients with central retinal artery occlusion in the Eagle study population by Leisser, C., Kaufmann, T. A., Feltgen, N., Schumacher, M., Schmoor, C., Meckel, S.

“…Purpose Arterial emboli in the internal carotid artery (ICA) mainly cause cerebral ischemia; only 10 % of emboli reach the retinal arteries. Computational…”
Get full text

Vitrectomy with and without encircling band for pseudophakic retinal detachment with inferior breaks: VIPER Study Report No. 3 by Baumgarten, Sabine, Schiller, Petra, Hellmich, Martin, Walter, Peter, Agostini, Hansjürgen, Junker, Bernd, Helbig, Horst, Lommatzsch, Albrecht, Mazinani, Babac

“…Purpose To test if an encircling band improves outcomes in vitrectomy for pseudophakic retinal detachment (PRD) with inferior or with multiple (4 or more)…”
Get full text

Multicenter study of the European Assessment Group for Lysis in the Eye (EAGLE) for the treatment of central retinal artery occlusion: design issues and implications. EAGLE Study report no. 1: EAGLE Study report no. 1 by Feltgen, N., Neubauer, A., Jurklies, B., Schmoor, C., Schmidt, D., Wanke, J., Maier-Lenz, H., Schumacher, M.

“…The natural course of central retinal artery occlusion (CRAO) often leads to legal blindness in the affected eye. To date, none of the conservative therapies…”
Get full text

Prospective noninterventional BLUE SKY study evaluating the efficacy of brolucizumab in treatment-naïve and previously treated patients with neovascular AMD by Faatz, H, Feltgen, N, Gutfleisch, M, Heimes-Bussmann, B, Krohne, T U, Liakopoulos, S, Liegl, R, Lommatzsch, A, Mussinghoff, P, Rehak, M, Schmitz-Valckenberg, S, Spital, G, Stanzel, B, Ziemssen, F, Hägele, B, Junkes, C, Porstner, M, Vögeler, J, Gmeiner, B, Pauleikhoff, D

“…Intravitreal injection of anti-vascular endothelial growth factor (VEGF) is the standard treatment for patients with neovascular age-related macular…”
Get more information

Feasibility of intravitreal erythropoietin injections in humans by Lagrèze, W A, Feltgen, N, Bach, M, Jehle, T

“…Preclinical data suggest that intravitreally administered erythropoietin (EPO) is both neuroprotective and safe. In a small pilot series, we intended to assess…”
Get more information

Retinal artery occlusion by Feltgen, N, Pielen, A

“…Retinal artery occlusion leads to profound visual impairment in the affected eye. It is rarely caused by local ophthalmic pathologies. Most patients present…”
Get full text

Clinical diagnostics and therapy for non-arteritic central retinal artery occlusion by Pielen, A, Junker, B, Hansen, L, Agostini, H, Feltgen, N

“…Central retinal artery occlusion (CRAO) is an ophthalmological emergency situation. Known risk factors are arterial hypertension, cardial arrhythmia,…”
Get more information

Treatment of central retinal vein occlusion by radial optic neurotomy in 107 cases by Hasselbach, H C, Ruefer, F, Feltgen, N, Schneider, U, Bopp, S, Hansen, L L, Hoerauf, H, Bartz-Schmidt, U, Roider, J

“…To evaluate the potential role of radial optic neurotomy (RON), a new surgical technique has been recently proposed for treating central retinal vein occlusion…”
Get full text

Intravitreal drug therapy for retinal vein occlusion--pathophysiological mechanisms and routinely used drugs by Feltgen, N, Pielen, A, Hansen, L, Bertram, B, Agostini, H, Jaissle, G B, Hoerauf, H, Stahl, A

“…The novel therapeutic principle of intravitreal drug therapy for retinal vein occlusion has become an integrated constituent of clinical practice over the last…”
Get more information

Central retinal artery occlusion: findings in optical coherence tomography and functional correlations by Schmidt, Dieter, Kube, T, Feltgen, N

“…Visual prognosis in central retinal artery occlusion (CRAO) is poor and not predictable in individual patients. There may be a correlation between visual…”
Get more information

Oral anticoagulation : Current overview and perioperative management in ophthalmic surgery by Sucker, C, Hager, A, Koscielny, J, Feltgen, N

“…Antithrombotic treatment with oral anticoagulants and antiplatelet agents can increase the risk for perioperative bleeding. In contrast to other surgical…”
Get full text

Recommendations of the DGAI, BDA, DOG, BDOC and BVA on anesthesiological care in ophthalmic surgery : In the version from 3 March 2021 by Castello, R, Neth, J, Hoerauf, H, Ach, T, Bachmann, W, Priglinger, S, Gamringer-Kroher, M, Bertram, B, Feltgen, N

Get full text